Monamycin D1 (8CI,9CI)(28045-02-5)
- Name: Monamycin D1 (8CI,9CI)
- Synonyms:2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazacyclooctadecine,cyclic peptide deriv.; D-Valine, N-[1-[N-[[2-[[D-hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;N-[1-[N-[[2-[[D-Hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-valinep-lactone
- Molecular Formula:C34H57 N7 O8
- Molecular Weight:
- CAS Registry Number:28045-02-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.28045-02-5 Monamycin D1 (8CI,9CI)
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 6272-83-9/N-[(2Z)-3-(2-ethoxyethyl)-6-nitro-1,3-benzothiazol-2(3H)-ylidene]furan-2-carboxamide
- 94107-94-5/sodium 1-amino-9,10-dihydro-4-[[3-[[(1-methylethyl)amino]carbonyl]phenyl]amino]-9,10-dioxoanthracen-2-sulphonate
- 130029-17-3/2-(4-amino-2-oxo-pyrimidin-1-yl)ethoxymethyl-(hydroxy-phosphonooxy-phosphoryl)oxy-phosphinic acid
- 8022-79-5/Oils, verbena, Spanish
- 85603-37-8/1-ethoxy-1,1-diphenyl-3-piperidin-1-ylpropan-2-one hydrobromide
- 28233-80-9/2α,9-Dihydroxy-21-methyl-6,21-secohetisan-6,7,13-trione
- 84964-50-1/Piperazine, 1-(6,11-dihydro-11-phenyldibenzo(b,e)thiepin-3-yl)-4-methy l-, (Z)-2-butenedioate (1:1), hydrate
- 84645-57-8/diethyl [4-(2-ethoxy-2-oxoethyl)-4-hydroxy-3-phenyl-1,3-thiazolidin-2-ylidene]propanedioate
- 130009-40-4/3H-Cyclobut[a]inden-3-one,4-(acetyloxy)decahydro-5,6a,7-trihydroxy-1,1,2b,6-tetramethyl-,(2aS,2bR,4R,5S,6R,6aS,7S,7aS)-
- 707-99-3/2-(6-Aminopurin-9-yl)ethanol
- 17668-31-4/dichloroplatinum(2+) propane-1,2-diyldiazanide
- 23552-76-3/1-hydroxy-4-[(4-methoxyphenyl)amino]anthraquinone
- 5014-12-0/3a-bromo-6-[hydroxy(phenyl)pyridin-2-ylmethyl]-8-[phenyl(pyridin-2-yl)methylidene]-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
- 50933-70-5/Roncovite
- 557-99-3/Acetyl fluoride
- 88343-73-1/2-fluoroethyl (methylsulfonyl)methanesulfonate
- 86873-12-3/Glycine, N,N-diethyl-, (5,7-dichloro-1,2-dihydro-2-oxo-3H-indol-3-ylid ene)hydrazide, (Z)-
- 65691-00-1/5-(4-chlorophenyl)-2,3-diphenyl-thiophene
- 102805-45-8/[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
- 28045-02-5/Monamycin D1 (8CI,9CI)
- 93107-34-7/PD158804
- 7678-00-4/5-diazonio-6-oxo-1,6-dihydropyrimidin-2-olate hydrate (1:1)
- 149338-25-0/5-chloro-N-(4-chlorophenyl)-2-nitro-1-benzothiophen-3-amine
- 51484-68-5/Aluminum, (glycinato-N,O)dihydroxy-
- 74472-34-7/2,3,4',5-TETRACHLOROBIPHENYL
- 383-50-6/2-Fluoroethyl 4-methylbenzenesulfonate
- 19550-56-2/2,9-DIMETHYL-5-DECYNE
- 36145-08-1/O-(3-chloro-7-methylpyrazolo[1,5-a]pyrimidin-2-yl) O,O-diethyl thiophosphate
- 143760-08-1/1-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-3-[(4-methoxyphenyl)sulfanyl]propan-2-ol
- 15215-74-4/methyl N-(tert-butoxycarbonyl)phenylalanylphenylalaninate